| About the author: |
Pypa L.V., Lysytsia Yu.N., Svistilnik R.V., Bulat L.M. |
| Heading |
CLINICAL MEDICINE |
| Type of article |
Scentific article |
| Annotation |
The work was aimed to study the confidence and significance of anxiety in the occurrence of somatoform disorders (SD) in children, to establish the role of serotonin and tryptophan in its development. 111 children were diagnosed with SD. In 109 (98,2%) children were diagnosed with excessive anxiety. Serotonin levels in children with personality and reactive anxiety were 1,16 ± 0,33 μmol/l and 1,17 ± 0,33 μmol/l, respectively and were lower compared to the control group, where its level reached 1,35 ± 0,34 μmol/l (p<0,004 and p<0,008, respectively). The level of serotonin in patients with anxiety in combination with depression was lower compared with patients with anxiety without depression (p<0,0001). It is possible to suspect the existence of several subtypes of SD, where one can occur as a variant of depression with somatic manifestations and secondary anxiety in which serotonin metabolism may play a key role, whereas the second variant of SD can arise as a variant of anxiety disorder with somatic manifestations and somatic manifestations and secondary disorders as a personality response to a disease in which serotonin metabolism does not play a key role in the development of pathology. |
| Tags |
somatoform disorder, anxiety, serotonin, tryptophan, children |
| Bibliography |
- Chutko LS, Kornishina TL, Surushkina SYu, Yakovenko EA, Anisimova TI, Volov MB. Sindrom vegetativnoy disfunktsii u detey i podrostkov. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2018;118(1):43-49. doi:10.17116/jnevro20181181143-49 [in Russian]
- Drachuk TE, Drachuk LA, Peshikova MV. Profilaktika trevozhnykh rasstroystv u detey v usloviyakh psikhoterapevticheskogo kabineta detskoy polikliniki. Pediatricheskiy vestnik Yuzhnogo Urala. 2015; 2: 24-28. [in Russian]
- Iskakova UB, Abisheva ZS, Zhurunova MS, Zhetpisbaeva GD, Ismagulova TM. Situativnaya trevozhnost i psikho-emotsionalnoe sostoyanie studentov vo vremya rubezhnogo kontrolya Mezhdunarodnyy zhurnal prikladnykh i fundamentalnykh issledovaniy. 2016; 11:900-902. [in Russian]
- Agarwal V, Srivastava C, Sitholey P. Clinical practice guidelines for the management of somatoform disorders in children and adolescents. Indian J Psychiatry. 2019 Sep 2; 61(2):241-246. doi: 10.4103/psychiatry.IndianJPsychiatry_494_18.
- Albert PR, Vahid-Ansari F, Luckhart C. Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression. Front Behav Neurosci. 2014 Jun 6; 6(8):199. doi: 10.3389/fnbeh.2014.00199.
- Bujoreanu S, Randall E, Thomson K, Ibeziako P. Characteristics of medically hospitalized pediatric patients with somatoform diagnoses. Hosp Pediatr. 2016 Sep;4(5):283-90. doi: 10.1542/hpeds.2014-0023.
- Campo JV. Annual research review: functional somatic symptoms and associated anxiety and depression--developmental psychopathology in pediatric practice. J Child Psychol Psychiatry. 2012 May; 53(5):575-92. doi: 10.1111/j.1469-7610.2012.02535.x.
- Heimann P, Herpertz‑Dahlmann B, Buning J, Wagner N, Stollbrink-Peschgens C, Dempfle A, von Polier GG. Somatic symptom and related disorders in children and adolescents: evaluation of a naturalistic inpatient multidisciplinary treatment. Child Adolesc Psychiatry Ment Health. 2018 Jun 28; 12:34. doi: 10.1186/s13034-018-0239-y. eCollection 2018.
- Kurlansik SL, Maffei MS. Somatic symptom disorder. Am. Fam. Physician. 2015 Jan 1; 93(1):49-54.
- Mohapatra S, Deo Sardar JK, Satapathy A, Rath N. Somatoform disorders in children and adolescents. German J Psychiatry. 2014; 17(1):19-24.
- Müjgan ÖE, Nergis ASZ, Solmaz TA, Gülten EÜ. Somatization in Depression and Anxiety Disorders. The Journal of Psychiatry and Neurological Sciences. 2010;23:60-65. doi: 10.5350/DAJPN2010230109
- Muck-Seler D, Pivac N. Serotonin. Periodicum biologorum. 2011; 113(1):29–41.
- Pytliak M, Vargova V, Mechirova V, Felšöci M. Serotonin receptors—from molecular biology to clinical applications. Physiol Res. 2011; 60(1):15–25.
- Sachs BD, Ni JR., Caron MG. Brain 5-HT deficiency increases stress vulnerability and impairs antidepressant responses following psychosocial stress. PNAS. 2015 Feb 24; 112(8): 2557–2562. doi: 10.1073/pnas.1416866112.
- Shidhaye R, Mendenhall E, Sumathipala K, Sumathipala A, Patel V. Association of somatoform disorders with anxiety and depression in women in low and middle income countries: A systematic review. Int Rev Psychiatry. 2013 Feb; 25(1):65-76. doi: 10.3109/09540261.2012.748651.
|
| Publication of the article |
«World of Medicine and Biology» №1(71), 2020 year, 094-099 pages, index UDK 616.895.4:616.8906:616.1/6053.2 |
| DOI |
10.26724/2079-8334-2020-1-71-94-99 |
